{
    "abstract": "N-glycolylneuraminic acid (Neu5Gc)-containing glycans are a prominent form of aberrant glycosylation found in human tumor cells and have been proposed as cancer biomarkers. The B subunit of the subtilase cytotoxin (SubB) produced by Shiga toxigenic Escherichia coli recognises Neu5Gc containing glycans. We have previously engineered this lectin, SubB2M, for greater specificity and enhanced recognition of Neu5Gc-containing glycans. Here we further explore the utility of SubB2M to detect Neu5Gc tumor biomarkers in sera from patients with ovarian cancer. Using surface plasmon resonance (SPR) we show that SubB2M can detect the established ovarian cancer biomarker, CA125, in a highly sensitive and specific fashion in the context of human serum. These studies established conditions for screening serum samples from patients with ovarian cancer for Neu5Gc glycans. We found that serum from patients with all stages of ovarian cancer had significantly elevated mean levels of Neu5Gc glycans compared to normal controls. Serum from patients with late stage disease (stages IIIC, IV) had uniformly elevated levels of Neu5Gc glycans. Detection of Neu5Gc-glycans using SubB2M has the potential to be used as a diagnostic ovarian cancer biomarker, as well as a tool for monitoring treatment and disease progression in late stage disease.",
    "author_highlights": [
        {
            "endOffset": 9301,
            "sentence": "N-glycolylneuraminic acid (Neu5Gc) has been proposed as cancer biomarker.",
            "startOffset": 9228
        },
        {
            "endOffset": 9378,
            "sentence": "A Neu5Gc-specific lectin, SubB2M, was used to detect Neu5Gc in patient sera.",
            "startOffset": 9302
        },
        {
            "endOffset": 9455,
            "sentence": "Serum from ovarian cancer patients has significantly elevated Neu5Gc levels.",
            "startOffset": 9379
        },
        {
            "endOffset": 9540,
            "sentence": "Late stage ovarian cancer patients have uniformly elevated levels of Neu5Gc-glycans.",
            "startOffset": 9456
        }
    ],
    "bib_entries": {
        "bib1": null,
        "bib10": {
            "authors": [
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Bergmann"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Beaugrand"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Labadie"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Bidart"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Bohuon"
                }
            ],
            "doi": "10.1016/0009-8981(86)90278-0",
            "firstpage": "163",
            "issn": "00098981",
            "lastpage": "165",
            "pmid": "3009058",
            "pub_year": 1986,
            "title": "CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases",
            "volume": "155"
        },
        "bib11": {
            "authors": [
                {
                    "first": "Tetsuo",
                    "initial": "T.",
                    "last": "Masahashi"
                },
                {
                    "first": "Katsuji",
                    "initial": "K.",
                    "last": "Matsuzawa"
                },
                {
                    "first": "Masami",
                    "initial": "M.",
                    "last": "Ohsawa"
                },
                {
                    "first": "Osamu",
                    "initial": "O.",
                    "last": "Narita"
                },
                {
                    "first": "Toyohiko",
                    "initial": "T.",
                    "last": "Asai"
                },
                {
                    "first": "Minoru",
                    "initial": "M.",
                    "last": "Ishihara"
                }
            ],
            "firstpage": "328",
            "issn": "00297844",
            "lastpage": "331",
            "pmid": "3165507",
            "pub_year": 1988,
            "title": "Serum CA 125 levels in patients with endometriosis: Changes in CA 125 levels during menstruation",
            "volume": "72"
        },
        "bib12": {
            "authors": [
                {
                    "first": "Patrizia",
                    "initial": "P.",
                    "last": "Bottoni"
                },
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Scatena"
                }
            ],
            "doi": "10.1007/978-94-017-7215-0_14",
            "firstpage": "229",
            "issn": "00652598",
            "lastpage": "244",
            "pmid": "26530369",
            "pub_year": 2015,
            "title": "The role of CA 125 as tumor marker: Biochemical and clinical aspects",
            "volume": "867"
        },
        "bib13": {
            "authors": [
                {
                    "first": "Nissi M.",
                    "initial": "N.M.",
                    "last": "Varki"
                },
                {
                    "first": "Ajit",
                    "initial": "A.",
                    "last": "Varki"
                }
            ],
            "doi": "10.1038/labinvest.3700656",
            "firstpage": "851",
            "issn": "00236837",
            "lastpage": "857",
            "pmid": "17632542",
            "pub_year": 2007,
            "title": "Diversity in cell surface sialic acid presentations: Implications for biology and disease",
            "volume": "87"
        },
        "bib14": {
            "authors": [
                {
                    "first": "Hsun Hua",
                    "initial": "H.H.",
                    "last": "Chou"
                },
                {
                    "first": "Toshiyuki",
                    "initial": "T.",
                    "last": "Hayakawa"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Diaz"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Krings"
                },
                {
                    "first": "Etty",
                    "initial": "E.",
                    "last": "Indriati"
                },
                {
                    "first": "Meave",
                    "initial": "M.",
                    "last": "Leakey"
                },
                {
                    "first": "Svante",
                    "initial": "S.",
                    "last": "Paabo"
                },
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Satta"
                },
                {
                    "first": "Naoyuki",
                    "initial": "N.",
                    "last": "Takahata"
                },
                {
                    "first": "Ajit",
                    "initial": "A.",
                    "last": "Varki"
                }
            ],
            "doi": "10.1073/pnas.182257399",
            "firstpage": "11736",
            "issn": "00278424",
            "lastpage": "11741",
            "pmid": "12192086",
            "pub_year": 2002,
            "title": "Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution",
            "volume": "99"
        },
        "bib15": {
            "authors": [
                {
                    "first": "Sadako",
                    "initial": "S.",
                    "last": "Inoue"
                },
                {
                    "first": "Chihiro",
                    "initial": "C.",
                    "last": "Sato"
                },
                {
                    "first": "Ken",
                    "initial": "K.",
                    "last": "Kitajima"
                }
            ],
            "doi": "10.1093/glycob/cwq030",
            "firstpage": "752",
            "issn": "09596658",
            "lastpage": "762",
            "pmid": "20197272",
            "pub_year": 2010,
            "title": "Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells",
            "volume": "20"
        },
        "bib16": {
            "authors": [
                {
                    "first": "Annie N.",
                    "initial": "A.N.",
                    "last": "Samraj"
                },
                {
                    "first": "Heinz",
                    "initial": "H.",
                    "last": "L\u00e4ubli"
                },
                {
                    "first": "Nissi",
                    "initial": "N.",
                    "last": "Varki"
                },
                {
                    "first": "Ajit",
                    "initial": "A.",
                    "last": "Varki"
                }
            ],
            "doi": "10.3389/fonc.2014.00033",
            "issn": "2234943X",
            "pub_year": 2014,
            "title": "Involvement of a non-human sialic acid in human cancer",
            "volume": "4"
        },
        "bib17": {
            "authors": [
                {
                    "first": "Hideyoshi",
                    "initial": "H.",
                    "last": "Higashi"
                },
                {
                    "first": "Yukio",
                    "initial": "Y.",
                    "last": "Fukui"
                },
                {
                    "first": "Shigeharu",
                    "initial": "S.",
                    "last": "Ueda"
                },
                {
                    "first": "Shiro",
                    "initial": "S.",
                    "last": "Kato"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Matsumoto"
                },
                {
                    "first": "Masaharu",
                    "initial": "M.",
                    "last": "Naiki"
                }
            ],
            "firstpage": "3796",
            "issn": "00085472",
            "lastpage": "3802",
            "pmid": "3874688",
            "pub_year": 1985,
            "title": "Characterization of N-Glycolylneuraminic Acid-containing Gangliosides as Tumor-associated Hanganutziu-Deicher Antigen in Human Colon Cancer",
            "volume": "45"
        },
        "bib18": {
            "authors": [
                {
                    "first": "Y. N.",
                    "initial": "Y.N.",
                    "last": "Malykh"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schauer"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Shaw"
                }
            ],
            "doi": "10.1016/S0300-9084(01)01303-7",
            "firstpage": "623",
            "issn": "03009084",
            "lastpage": "634",
            "pmid": "11522391",
            "pub_year": 2001,
            "title": "N-Glycolylneuraminic acid in human tumours",
            "volume": "83"
        },
        "bib19": {
            "authors": [
                {
                    "first": "Jun Ichi",
                    "initial": "J.I.",
                    "last": "Furukawa"
                },
                {
                    "first": "Masumi",
                    "initial": "M.",
                    "last": "Tsuda"
                },
                {
                    "first": "Kazue",
                    "initial": "K.",
                    "last": "Okada"
                },
                {
                    "first": "Taichi",
                    "initial": "T.",
                    "last": "Kimura"
                },
                {
                    "first": "Jinhua",
                    "initial": "J.",
                    "last": "Piao"
                },
                {
                    "first": "Shinya",
                    "initial": "S.",
                    "last": "Tanaka"
                },
                {
                    "first": "Yasuro",
                    "initial": "Y.",
                    "last": "Shinohara"
                }
            ],
            "doi": "10.1371/journal.pone.0128300",
            "issn": "19326203",
            "pmid": "26132161",
            "pub_year": 2015,
            "title": "Comprehensive glycomics of a multistep human brain tumor model reveals specific glycosylation patterns related to malignancy",
            "volume": "10"
        },
        "bib2": null,
        "bib20": {
            "authors": [
                {
                    "first": "Gilda",
                    "initial": "G.",
                    "last": "Marquina"
                },
                {
                    "first": "Hatsue",
                    "initial": "H.",
                    "last": "Waki"
                },
                {
                    "first": "Luis E.",
                    "initial": "L.E.",
                    "last": "Fernandez"
                },
                {
                    "first": "Kazuo",
                    "initial": "K.",
                    "last": "Kon"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "Carr"
                },
                {
                    "first": "Oscar",
                    "initial": "O.",
                    "last": "Valiente"
                },
                {
                    "first": "Rolando",
                    "initial": "R.",
                    "last": "Perez"
                },
                {
                    "first": "Susumu",
                    "initial": "S.",
                    "last": "Ando"
                }
            ],
            "firstpage": "5165",
            "issn": "00085472",
            "lastpage": "5171",
            "pmid": "8912852",
            "pub_year": 1996,
            "title": "Gangliosides expressed in human breast cancer",
            "volume": "56"
        },
        "bib21": {
            "authors": [
                {
                    "first": "Hideyoshi",
                    "initial": "H.",
                    "last": "Higashi"
                },
                {
                    "first": "Tetsuo",
                    "initial": "T.",
                    "last": "Sasabe"
                },
                {
                    "first": "Yukio",
                    "initial": "Y.",
                    "last": "Fukui"
                },
                {
                    "first": "Morimasa",
                    "initial": "M.",
                    "last": "Maru"
                },
                {
                    "first": "Shiro",
                    "initial": "S.",
                    "last": "Kato"
                }
            ],
            "doi": "10.1111/j.1349-7006.1988.tb00060.x",
            "firstpage": "952",
            "issn": "09105050",
            "lastpage": "956",
            "pmid": "2460424",
            "pub_year": 1988,
            "title": "Detection of Gangliosides as N\u2010Glycolylneuraminic Acid\u2010specific Tumor\u2010associated Hanganutziu\u2010Deicher Antigen in Human Retinoblastoma Cells",
            "volume": "79"
        },
        "bib22": {
            "authors": [
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Priego-Capote"
                },
                {
                    "first": "M. I.",
                    "initial": "M.I.",
                    "last": "Orozco-Solano"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Calder\u00f3n-Santiago"
                },
                {
                    "first": "M. D.",
                    "initial": "M.D.",
                    "last": "Luque de Castro"
                }
            ],
            "doi": "10.1016/j.chroma.2014.04.051",
            "firstpage": "88",
            "issn": "00219673",
            "lastpage": "96",
            "pmid": "24800968",
            "pub_year": 2014,
            "title": "Quantitative determination and confirmatory analysis of N-acetylneuraminic and N-glycolylneuraminic acids in serum and urine by solid-phase extraction on-line coupled to liquid chromatography-tandem mass spectrometry",
            "volume": "1346"
        },
        "bib23": {
            "authors": [
                {
                    "first": "Ken",
                    "initial": "K.",
                    "last": "Kitajima"
                },
                {
                    "first": "Nissi",
                    "initial": "N.",
                    "last": "Varki"
                },
                {
                    "first": "Chihiro",
                    "initial": "C.",
                    "last": "Sato"
                }
            ],
            "doi": "10.1007/128_2013_458",
            "firstpage": "75",
            "issn": "03401022",
            "lastpage": "104",
            "pmid": "26017094",
            "pub_year": 2015,
            "title": "Advanced technologies in sialic acid and sialoglycoconjugate analysis",
            "volume": "367"
        },
        "bib24": {
            "authors": [
                {
                    "first": "Sandra L.",
                    "initial": "S.L.",
                    "last": "Diaz"
                },
                {
                    "first": "Vered",
                    "initial": "V.",
                    "last": "Padler-Karavani"
                },
                {
                    "first": "Darius",
                    "initial": "D.",
                    "last": "Ghaderi"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Hurtado-Ziola"
                },
                {
                    "first": "Hai",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Xi",
                    "initial": "X.",
                    "last": "Chen"
                },
                {
                    "first": "Els C.M.",
                    "initial": "E.C.M.",
                    "last": "Brinkman-Van der Linden"
                },
                {
                    "first": "Ajit",
                    "initial": "A.",
                    "last": "Varki"
                },
                {
                    "first": "Nissi M.",
                    "initial": "N.M.",
                    "last": "Varki"
                }
            ],
            "doi": "10.1371/journal.pone.0004241",
            "issn": "19326203",
            "pmid": "19156207",
            "pub_year": 2009,
            "title": "Sensitive and specific detection of the non-human sialic acid N-Glycolylneuraminic acid in human tissues and biotherapeutic products",
            "volume": "4"
        },
        "bib25": {
            "authors": [
                {
                    "first": "Christopher J.",
                    "initial": "C.J.",
                    "last": "Day"
                },
                {
                    "first": "Adrienne W.",
                    "initial": "A.W.",
                    "last": "Paton"
                },
                {
                    "first": "Melanie A.",
                    "initial": "M.A.",
                    "last": "Higgins"
                },
                {
                    "first": "Lucy K.",
                    "initial": "L.K.",
                    "last": "Shewell"
                },
                {
                    "first": "Freda E.C.",
                    "initial": "F.E.C.",
                    "last": "Jen"
                },
                {
                    "first": "Benjamin L.",
                    "initial": "B.L.",
                    "last": "Schulz"
                },
                {
                    "first": "Brock P.",
                    "initial": "B.P.",
                    "last": "Herdman"
                },
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Paton"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Jennings"
                }
            ],
            "doi": "10.1038/s41598-017-01522-9",
            "issn": "20452322",
            "pmid": "28473713",
            "pub_year": 2017,
            "title": "Structure aided design of a Neu5Gc specific lectin",
            "volume": "7"
        },
        "bib26": {
            "authors": [
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Lucy K.",
                    "initial": "L.K.",
                    "last": "Shewell"
                },
                {
                    "first": "Adrienne W.",
                    "initial": "A.W.",
                    "last": "Paton"
                },
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Paton"
                },
                {
                    "first": "Christopher J.",
                    "initial": "C.J.",
                    "last": "Day"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "Jennings"
                }
            ],
            "doi": "10.1016/j.bbrc.2018.04.151",
            "firstpage": "765",
            "issn": "0006291X",
            "lastpage": "771",
            "pmid": "29684349",
            "pub_year": 2018,
            "title": "Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin",
            "volume": "500"
        },
        "bib27": {
            "authors": [
                {
                    "first": "Adrienne W.",
                    "initial": "A.W.",
                    "last": "Paton"
                },
                {
                    "first": "Potjanee",
                    "initial": "P.",
                    "last": "Srimanote"
                },
                {
                    "first": "Ursula M.",
                    "initial": "U.M.",
                    "last": "Talbot"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "James C.",
                    "initial": "J.C.",
                    "last": "Paton"
                }
            ],
            "doi": "10.1084/jem.20040392",
            "firstpage": "35",
            "issn": "00221007",
            "lastpage": "46",
            "pmid": "15226357",
            "pub_year": 2004,
            "title": "A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli",
            "volume": "200"
        },
        "bib28": {
            "authors": [
                {
                    "first": "Christopher J.",
                    "initial": "C.J.",
                    "last": "Day"
                },
                {
                    "first": "Victoria",
                    "initial": "V.",
                    "last": "Korolik"
                }
            ],
            "doi": "10.1007/978-1-4939-7577-8_24",
            "firstpage": "303",
            "issn": "10643745",
            "lastpage": "317",
            "pmid": "29429100",
            "pub_year": 2018,
            "title": "Identification of specific ligands for sensory receptors by small-molecule ligand arrays and surface plasmon resonance",
            "volume": "1729"
        },
        "bib29": {
            "authors": [
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Klug"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Bast"
                },
                {
                    "first": "Jonathan M.",
                    "initial": "J.M.",
                    "last": "Niloff"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Knapp"
                },
                {
                    "first": "Vincent R.",
                    "initial": "V.R.",
                    "last": "Zurawski"
                }
            ],
            "firstpage": "1048",
            "issn": "00085472",
            "lastpage": "1053",
            "pmid": "6198078",
            "pub_year": 1984,
            "title": "Monoclonal Antibody Immunoradiometric Assay for an Antigenic Determinant (CA 125) Associated with Human Epithelial Ovarian Carcinomas",
            "volume": "44"
        },
        "bib3": {
            "authors": [
                {
                    "first": "Beatrice W.T.",
                    "initial": "B.W.T.",
                    "last": "Yin"
                },
                {
                    "first": "Kenneth O.",
                    "initial": "K.O.",
                    "last": "Lloyd"
                }
            ],
            "doi": "10.1074/jbc.M103554200",
            "firstpage": "27371",
            "issn": "00219258",
            "lastpage": "27375",
            "pmid": "11369781",
            "pub_year": 2001,
            "title": "Molecular cloning of the CA125 ovarian cancer antigen: Identification as a new mucin, MUC16",
            "volume": "276"
        },
        "bib30": {
            "authors": [
                {
                    "first": "Radka",
                    "initial": "R.",
                    "last": "Saldova"
                },
                {
                    "first": "Weston B.",
                    "initial": "W.B.",
                    "last": "Struwe"
                },
                {
                    "first": "Kieran",
                    "initial": "K.",
                    "last": "Wynne"
                },
                {
                    "first": "Giuliano",
                    "initial": "G.",
                    "last": "Elia"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Duffy"
                },
                {
                    "first": "Pauline M.",
                    "initial": "P.M.",
                    "last": "Rudd"
                }
            ],
            "doi": "10.3390/ijms140815636",
            "firstpage": "15636",
            "issn": "16616596",
            "lastpage": "15654",
            "pmid": "23896595",
            "pub_year": 2013,
            "title": "Exploring the glycosylation of serum CA125",
            "volume": "14"
        },
        "bib31": {
            "authors": [
                {
                    "first": "Richard G.",
                    "initial": "R.G.",
                    "last": "Moore"
                },
                {
                    "first": "Amy K.",
                    "initial": "A.K.",
                    "last": "Brown"
                },
                {
                    "first": "M. Craig",
                    "initial": "M.C.",
                    "last": "Miller"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Skates"
                },
                {
                    "first": "W. Jeffrey",
                    "initial": "W.J.",
                    "last": "Allard"
                },
                {
                    "first": "Thorsten",
                    "initial": "T.",
                    "last": "Verch"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "Steinhoff"
                },
                {
                    "first": "Geralyn",
                    "initial": "G.",
                    "last": "Messerlian"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "DiSilvestro"
                },
                {
                    "first": "C. O.",
                    "initial": "C.O.",
                    "last": "Granai"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Bast"
                }
            ],
            "doi": "10.1016/j.ygyno.2007.10.017",
            "firstpage": "402",
            "issn": "00908258",
            "lastpage": "408",
            "pmid": "18061248",
            "pub_year": 2008,
            "title": "The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass",
            "volume": "108"
        },
        "bib32": {
            "authors": [
                {
                    "first": "Armin",
                    "initial": "A.",
                    "last": "Rump"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Morikawa"
                },
                {
                    "first": "Minoru",
                    "initial": "M.",
                    "last": "Tanaka"
                },
                {
                    "first": "Sawako",
                    "initial": "S.",
                    "last": "Minami"
                },
                {
                    "first": "Naohiko",
                    "initial": "N.",
                    "last": "Umesaki"
                },
                {
                    "first": "Masaki",
                    "initial": "M.",
                    "last": "Takeuchi"
                },
                {
                    "first": "Atsushi",
                    "initial": "A.",
                    "last": "Miyajima"
                }
            ],
            "doi": "10.1074/jbc.M312372200",
            "firstpage": "9190",
            "issn": "00219258",
            "lastpage": "9198",
            "pmid": "14676194",
            "pub_year": 2004,
            "title": "Binding of Ovarian Cancer Antigen CA125/MUC61 to Mesothelin Mediates Cell Adhesion",
            "volume": "279"
        },
        "bib33": {
            "authors": [
                {
                    "first": "Jean Francois",
                    "initial": "J.F.",
                    "last": "Masson"
                }
            ],
            "doi": "10.1021/acssensors.6b00763",
            "firstpage": "16",
            "issn": "23793694",
            "lastpage": "30",
            "pmid": "28722437",
            "pub_year": 2017,
            "title": "Surface Plasmon Resonance Clinical Biosensors for Medical Diagnostics",
            "volume": "2"
        },
        "bib34": {
            "authors": [
                {
                    "first": "Pam",
                    "initial": "P.",
                    "last": "Tangvoranuntakul"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Gagneux"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Diaz"
                },
                {
                    "first": "Muriel",
                    "initial": "M.",
                    "last": "Bardor"
                },
                {
                    "first": "Nissi",
                    "initial": "N.",
                    "last": "Varki"
                },
                {
                    "first": "Ajit",
                    "initial": "A.",
                    "last": "Varki"
                },
                {
                    "first": "Elaine",
                    "initial": "E.",
                    "last": "Muchmore"
                }
            ],
            "doi": "10.1073/pnas.2131556100",
            "firstpage": "12045",
            "issn": "00278424",
            "lastpage": "12050",
            "pmid": "14523234",
            "pub_year": 2003,
            "title": "Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid",
            "volume": "100"
        },
        "bib35": {
            "authors": [
                {
                    "first": "Paula A.",
                    "initial": "P.A.",
                    "last": "Bousquet"
                },
                {
                    "first": "Joe Alexander",
                    "initial": "J.A.",
                    "last": "Sandvik"
                },
                {
                    "first": "Nina F.",
                    "initial": "N.F.",
                    "last": "Jeppesen Edin"
                },
                {
                    "first": "Ute",
                    "initial": "U.",
                    "last": "Krengel"
                }
            ],
            "doi": "10.1016/j.bbrc.2017.11.183",
            "firstpage": "1562",
            "issn": "0006291X",
            "lastpage": "1566",
            "pmid": "29196263",
            "pub_year": 2018,
            "title": "Hypothesis: Hypoxia induces de novo synthesis of NeuGc gangliosides in humans through CMAH domain substitute",
            "volume": "495"
        },
        "bib4": {
            "authors": [
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Bast"
                },
                {
                    "first": "Thomas L.",
                    "initial": "T.L.",
                    "last": "Klug"
                },
                {
                    "first": "Elena St",
                    "initial": "E.S.",
                    "last": "John"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Jenison"
                },
                {
                    "first": "Jonathan M.",
                    "initial": "J.M.",
                    "last": "Niloff"
                },
                {
                    "first": "Herbert",
                    "initial": "H.",
                    "last": "Lazarus"
                },
                {
                    "first": "Ross S.",
                    "initial": "R.S.",
                    "last": "Berkowitz"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Leavitt"
                },
                {
                    "first": "C. Thomas",
                    "initial": "C.T.",
                    "last": "Griffiths"
                },
                {
                    "first": "Leroy",
                    "initial": "L.",
                    "last": "Parker"
                },
                {
                    "first": "Vincent R.",
                    "initial": "V.R.",
                    "last": "Zurawski"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Knapp"
                }
            ],
            "doi": "10.1056/NEJM198310133091503",
            "firstpage": "883",
            "issn": "00284793",
            "lastpage": "887",
            "pub_year": 1983,
            "title": "A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer",
            "volume": "309"
        },
        "bib5": {
            "authors": [
                {
                    "first": "Linda C.",
                    "initial": "L.C.",
                    "last": "Giudice"
                },
                {
                    "first": "Allan J.",
                    "initial": "A.J.",
                    "last": "Jacobs"
                },
                {
                    "first": "C. Elliot",
                    "initial": "C.E.",
                    "last": "Bell"
                },
                {
                    "first": "Lynne",
                    "initial": "L.",
                    "last": "Lippmann"
                }
            ],
            "doi": "10.1016/0090-8258(86)90107-1",
            "firstpage": "256",
            "issn": "00908258",
            "lastpage": "258",
            "pmid": "3463522",
            "pub_year": 1986,
            "title": "Letter to the editor",
            "volume": "25"
        },
        "bib6": {
            "authors": [
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Haga"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sakamoto"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Egami"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Yoshimura"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Akagi"
                }
            ],
            "doi": "10.1097/00000441-198607000-00005",
            "firstpage": "25",
            "issn": "00029629",
            "lastpage": "29",
            "pub_year": 1986,
            "title": "Evaluation of serum CA125 values in healthy individuals and pregnant women",
            "volume": "292"
        },
        "bib7": {
            "authors": [
                {
                    "first": "Donald E.",
                    "initial": "D.E.",
                    "last": "Pittaway"
                },
                {
                    "first": "Jamil A.",
                    "initial": "J.A.",
                    "last": "Fayez"
                },
                {
                    "first": "James W.",
                    "initial": "J.W.",
                    "last": "Douglas"
                }
            ],
            "doi": "10.1016/S0002-9378(87)80237-5",
            "firstpage": "1426",
            "issn": "00029378",
            "lastpage": "1428",
            "pmid": "3480690",
            "pub_year": 1987,
            "title": "Serum CA-125 in the evaluation of benign adnexal cysts",
            "volume": "157"
        },
        "bib8": {
            "authors": [
                {
                    "first": "Hannu",
                    "initial": "H.",
                    "last": "Halila"
                },
                {
                    "first": "Ulf\u2010H\u01cekan \u2010H",
                    "initial": "U.\u2010.",
                    "last": "Stenman"
                },
                {
                    "first": "Markku",
                    "initial": "M.",
                    "last": "Sepp\u00e4l\u00e4"
                }
            ],
            "doi": "10.1002/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z",
            "firstpage": "1327",
            "issn": "0008543X",
            "lastpage": "1329",
            "pmid": "3456253",
            "pub_year": 1986,
            "title": "Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy",
            "volume": "57"
        },
        "bib9": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ruibal"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Siurana"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Encabo"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Cuartero"
                }
            ],
            "firstpage": "376",
            "issn": "00257753",
            "lastpage": "377",
            "pmid": "3857424",
            "pub_year": 1985,
            "title": "Serum CA 1,25 in patients with non-ovarian tumors. Evidence of a relation between the increase of the antigen and hepatic disease",
            "volume": "84"
        }
    },
    "body_text": [
        {
            "endOffset": 22141,
            "parents": [],
            "secId": "sec4",
            "sentence": "This individual may have elevated levels of free Neu5Gc containing glycans, which may result in lower RUs compared to a serum sample with elevated levels of high-molecular weight Neu5Gc-containing glycoproteins or glycolipids.",
            "startOffset": 21915,
            "title": "Discussion"
        },
        {
            "endOffset": 10082,
            "parents": [],
            "refoffsets": {
                "bib2": {
                    "endOffset": 10023,
                    "startOffset": 10022
                }
            },
            "secId": "sec1",
            "sentence": "However, patients are typically diagnosed in the late stages due to the largely asymptomatic nature of this disease in the early stages [2] and the lack of highly sensitive and specific biomarkers.",
            "startOffset": 9885,
            "title": "Introduction"
        },
        {
            "endOffset": 17404,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "We note that SubB2M had superior sensitivity in detecting CA125 (14.65 CA125 units/ml) compared to the anti-CA125 mAb X325, which could only detect down to 58.6 CA125 units/ml.",
            "startOffset": 17228,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 20044,
            "parents": [],
            "secId": "sec4",
            "sentence": "Only 3 of the 12 samples with stage I ovarian cancer fell within this range while 5 out of 11 of the stage II ovarian cancer samples were within this range.",
            "startOffset": 19888,
            "title": "Discussion"
        },
        {
            "endOffset": 20315,
            "parents": [],
            "secId": "sec4",
            "sentence": "These data indicate that Neu5Gc levels are elevated in the majority of stage I/II ovarian cancer serum samples analysed in this study and that Neu5Gc-containing tumor antigens have the potential to serve as diagnostic markers for detection of early stage ovarian cancer.",
            "startOffset": 20045,
            "title": "Discussion"
        },
        {
            "endOffset": 22592,
            "parents": [],
            "refoffsets": {
                "bib15": {
                    "endOffset": 22590,
                    "startOffset": 22588
                },
                "bib34": {
                    "endOffset": 22505,
                    "startOffset": 22503
                }
            },
            "secId": "sec4",
            "sentence": "It has been reported that the origin of Neu5Gc in humans is dietary incorporation of this non-human glycan from animal sources, particularly red meat [34], and it is established that ovarian cancer cells secrete Neu5Gc glycoconjugates [15].",
            "startOffset": 22352,
            "title": "Discussion"
        },
        {
            "endOffset": 11596,
            "parents": [],
            "secId": "sec1",
            "sentence": "We engineered the B subunit of the Shiga toxigenic Escherichia coli (STEC) Subtilase cytotoxin (SubAB) to reduce the recognition of Neu5Ac and broaden the Neu5Gc linkage recognition.",
            "startOffset": 11414,
            "title": "Introduction"
        },
        {
            "endOffset": 17227,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "The anti-CA125 antibody, X325, also showed concentration-dependent detection of CA125 via SPR, verifying our method for detection of this human tumor antigen.",
            "startOffset": 17069,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 19285,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.3",
            "sentence": "There was no correlation between levels of Neu5Gc and CA125 levels for these 14 samples, suggesting that there are other Neu5Gc-containing biomarkers elevated in the serum of these ovarian cancer patients that remain to be identified.",
            "startOffset": 19051,
            "title": "Elevated Neu5Gc levels observed are not entirely due to elevated CA125 levels"
        },
        {
            "endOffset": 13497,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib28": {
                    "endOffset": 13303,
                    "startOffset": 13301
                },
                "bib29": {
                    "endOffset": 13267,
                    "startOffset": 13265
                },
                "bib30": {
                    "endOffset": 13426,
                    "startOffset": 13424
                },
                "bib31": {
                    "endOffset": 13461,
                    "startOffset": 13459
                },
                "bib4": {
                    "endOffset": 13495,
                    "startOffset": 13494
                }
            },
            "secId": "sec2.2",
            "sentence": "Normal female serum is reported to contain <35 units/ml of CA125 [4,29] or similar levels (63.2, 39.8) [28], while serum from patients with advanced stage ovarian cancer have been reported to contain 215.8\u20131977 CA125 units/ml [30], a mean of 645 CA125 units/ml [31] and up to 8100 CA125 units/ml [4].",
            "startOffset": 13197,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 15014,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.4",
            "sentence": "Statistical analysis was performed using GraphPad Prism 5.0.",
            "startOffset": 14954,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 14346,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.3",
            "sentence": "22 serum samples from normal human females, 12 serum samples from patients with stage I ovarian cancer, 11 with stage II ovarian cancer, 10 with stage IIIC ovarian cancer and 14 with stage IV ovarian cancer were obtained from the Victorian Cancer Biobank under application 17020.",
            "startOffset": 14067,
            "title": "Human serum samples"
        },
        {
            "endOffset": 22352,
            "parents": [],
            "secId": "sec4",
            "sentence": "Identifying and characterizing the Neu5Gc-containing glycoconjugates that are being detected by SubB2M and using these data to improve current ovarian cancer diagnostic methods is currently under investigation.",
            "startOffset": 22142,
            "title": "Discussion"
        },
        {
            "endOffset": 15403,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib26": {
                    "endOffset": 15401,
                    "startOffset": 15399
                }
            },
            "secId": "sec3.1",
            "sentence": "In our previous study we showed that SubB2M can detect bovine glycoproteins, known to be decorated with Neu5Gc, when spiked into normal human serum [26].",
            "startOffset": 15250,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 14463,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.3",
            "sentence": "\u2018Normal\u2019 controls are defined as patients with an apparent non-malignancy diagnosis at the time the sample is taken.",
            "startOffset": 14347,
            "title": "Human serum samples"
        },
        {
            "endOffset": 23318,
            "parents": [],
            "secId": "sec4",
            "sentence": "The detection of Neu5Gc-glycans using SubB2M has the potential to be used as a diagnostic tool, and as a liquid biopsy for monitoring treatment and disease progression.",
            "startOffset": 23150,
            "title": "Discussion"
        },
        {
            "endOffset": 17672,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "We next assessed whether the SubB2M lectin could detect elevated levels of Neu5Gc in serum samples from ovarian cancer patients with both early and late stage cancer.",
            "startOffset": 17506,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 23622,
            "parents": [],
            "secId": "sec7",
            "sentence": "Receiver operating characteristic (ROC) analysis of the data in Figure 2 was performed and revealed the ability of Neu5Gc levels to distinguish between two diagnostic groups (diseased/normal).",
            "startOffset": 23430,
            "title": "Note"
        },
        {
            "endOffset": 9719,
            "parents": [],
            "refoffsets": {
                "bib1": {
                    "endOffset": 9717,
                    "startOffset": 9716
                }
            },
            "secId": "sec1",
            "sentence": "Ovarian cancer has the highest rate of mortality among the gynecologic malignancies [1].",
            "startOffset": 9631,
            "title": "Introduction"
        },
        {
            "endOffset": 11150,
            "parents": [],
            "refoffsets": {
                "bib15": {
                    "endOffset": 11095,
                    "startOffset": 11090
                },
                "bib16": {
                    "endOffset": 11095,
                    "startOffset": 11090
                },
                "bib17": {
                    "endOffset": 11095,
                    "startOffset": 11090
                },
                "bib18": {
                    "endOffset": 11142,
                    "startOffset": 11140
                },
                "bib19": {
                    "endOffset": 11095,
                    "startOffset": 11090
                },
                "bib20": {
                    "endOffset": 11145,
                    "startOffset": 11143
                },
                "bib21": {
                    "endOffset": 11148,
                    "startOffset": 11146
                }
            },
            "secId": "sec1",
            "sentence": "However, Neu5Gc-containing glycans are found in human tumor tissues and cells [15\u201319] and have been proposed as a tumor antigen [18,20,21].",
            "startOffset": 11011,
            "title": "Introduction"
        },
        {
            "endOffset": 15185,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.4",
            "sentence": "The differences between normal serum samples compared to cancer patient serum samples were analysed by two-tailed t-tests, with a P value of <0.05 considered significant.",
            "startOffset": 15015,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 13196,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Human CA125 was serially diluted 1:2 from 75 units/ml to 0.1465 units/ml in 1% normal human serum with the range from 18.75 to 0.1465 units/ml (equivalent to 1875 units/ml \u2013 14.65 units/ml in 100% serum) shown in Fig. 1.",
            "startOffset": 12976,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 21369,
            "parents": [],
            "secId": "sec4",
            "sentence": "While dilution of the serum samples is advantageous in that very little sample is required from the patient for analysis, the dilution factor of serum samples from some patients may need to be individually optimized.",
            "startOffset": 21153,
            "title": "Discussion"
        },
        {
            "endOffset": 12975,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Human CA125 was spiked into 1% normal human serum diluted in PBS (the zero CA125 concentration control).",
            "startOffset": 12871,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 15535,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "In the current study, we investigated whether SubB2M could detect the human tumor antigen CA125 when present in normal human serum.",
            "startOffset": 15404,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 10236,
            "parents": [],
            "refoffsets": {
                "bib3": {
                    "endOffset": 10234,
                    "startOffset": 10233
                }
            },
            "secId": "sec1",
            "sentence": "The best currently available biomarker for ovarian cancer is the human cancer antigen 125 (CA125), also known as MUC16, a heavily glycosylated mucin [3].",
            "startOffset": 10083,
            "title": "Introduction"
        },
        {
            "endOffset": 11983,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib25": {
                    "endOffset": 11978,
                    "startOffset": 11976
                },
                "bib27": {
                    "endOffset": 11981,
                    "startOffset": 11979
                }
            },
            "secId": "sec2.1",
            "sentence": "The recombinant SubB2M protein was expressed and purified as previously described [25,27].",
            "startOffset": 11893,
            "title": "Expression and purification of SubB2M"
        },
        {
            "endOffset": 22696,
            "parents": [],
            "refoffsets": {
                "bib35": {
                    "endOffset": 22694,
                    "startOffset": 22692
                }
            },
            "secId": "sec4",
            "sentence": "However, it has recently been proposed that human cancer cells may also produce endogenous Neu5Gc [35].",
            "startOffset": 22593,
            "title": "Discussion"
        },
        {
            "endOffset": 12679,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "SubB2M (capture level: 4974\u20135483 Response Units (RU)) and anti-CA125 mAb X325 (Bio-Rad) (capture level: 6538\u20137531 RU) were immobilized onto flow cell 2 and 3 of a series S sensor chip CM5 (GE) using the NHS capture kit and flow cell 1 was run as a blank immobilisation.",
            "startOffset": 12410,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 14600,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.3",
            "sentence": "The patient data and serum samples used in this project were provided by the Victorian Cancer Biobank with appropriate ethical approval.",
            "startOffset": 14464,
            "title": "Human serum samples"
        },
        {
            "endOffset": 24109,
            "parents": [],
            "secId": "sec7",
            "sentence": "Area under the curve (AUC) values of 1.0 = 100% accurate diagnostic test: Normal vs Stage I: optimal cutoff = >62.94RU (sensitivity = 91.67%, specificity = 86.36%); AUC = 0.9053), Normal vs Stage II: optimal cutoff = >61.02RU (sensitivity = 90.91%, specificity = 81.82%); AUC = 0.9298, Normal vs Stage III: optimal cutoff = >162.9RU (sensitivity = 100%, specificity = 100%); AUC = 1.00, Normal vs Stage IV: optimal cutoff = >162.7RU (sensitivity = 100%, specificity = 100%); AUC = 1.00.",
            "startOffset": 23623,
            "title": "Note"
        },
        {
            "endOffset": 12870,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "Human cancer antigen 125 (CA125) was purchased from MyBioSource (San Diego, USA) and was purified from a human ovarian carcinoma cell line and provided at a concentration of 84,040 units/ml.",
            "startOffset": 12680,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 18064,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "The serum samples were collected immediately pre-operatively and were processed and stored within 2 h of collection.",
            "startOffset": 17948,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 13868,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "The serum samples were diluted 1:100 in PBS and analysed in duplicate individually.",
            "startOffset": 13785,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 9884,
            "parents": [],
            "secId": "sec1",
            "sentence": "The five-year survival rate is less than 20% in women diagnosed with late stage ovarian cancer but increases to over 90% when detected in early stages (stage I-II).",
            "startOffset": 9720,
            "title": "Introduction"
        },
        {
            "endOffset": 18845,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib4": {
                    "endOffset": 18710,
                    "startOffset": 18709
                }
            },
            "secId": "sec3.3",
            "sentence": "CA125 has been shown to be elevated in the serum of up to 80% of patients with ovarian cancer [4], therefore we were interested to know if the elevated levels of Neu5Gc being detected by SubB2M were due to elevated levels of CA125.",
            "startOffset": 18614,
            "title": "Elevated Neu5Gc levels observed are not entirely due to elevated CA125 levels"
        },
        {
            "endOffset": 11831,
            "parents": [],
            "secId": "sec1",
            "sentence": "Here we describe the analysis of serum samples from patients with ovarian cancer compared to normal, cancer-free females using SubB2M via surface plasmon resonance (SPR).",
            "startOffset": 11661,
            "title": "Introduction"
        },
        {
            "endOffset": 16444,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib26": {
                    "endOffset": 16442,
                    "startOffset": 16440
                }
            },
            "secId": "sec3.1",
            "sentence": "These spiked samples were prepared in 1% normal human serum, as our previous study showed that this dilution of human serum gave the best signal-to-noise ratio [26].",
            "startOffset": 16279,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 19475,
            "parents": [],
            "refoffsets": {
                "bib1": {
                    "endOffset": 19471,
                    "startOffset": 19470
                },
                "bib2": {
                    "endOffset": 19473,
                    "startOffset": 19472
                }
            },
            "secId": "sec4",
            "sentence": "Ovarian cancer has the highest mortality rate of the female reproductive cancers, mainly due to late diagnosis resulting from the lack of specific symptoms for this disease [1,2].",
            "startOffset": 19296,
            "title": "Discussion"
        },
        {
            "endOffset": 16278,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib30": {
                    "endOffset": 16276,
                    "startOffset": 16274
                },
                "bib4": {
                    "endOffset": 16143,
                    "startOffset": 16142
                }
            },
            "secId": "sec3.1",
            "sentence": "Purified CA125 from a human ovarian cancer cell line was spiked into normal human serum at concentrations found in normal female serum (<35 CA125 units/ml) [4] up to concentrations previously reported for serum from patients with advanced stage ovarian cancer (215.8\u20131977 CA125 units/ml) [30].",
            "startOffset": 15985,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 19579,
            "parents": [],
            "secId": "sec4",
            "sentence": "Methods for the detection of ovarian cancer in the early stages would therefore improve survival rates.",
            "startOffset": 19476,
            "title": "Discussion"
        },
        {
            "endOffset": 22934,
            "parents": [],
            "secId": "sec4",
            "sentence": "The capacity to diagnose ovarian cancer in early stages will have a significant impact on patient survival rates.",
            "startOffset": 22821,
            "title": "Discussion"
        },
        {
            "endOffset": 20510,
            "parents": [],
            "secId": "sec4",
            "sentence": "None of the serum samples from the stage IIIC and IV cancer patients fell within the normal ranges for Neu5Gc levels demonstrating that Neu5Gc is uniformly elevated in late stage ovarian cancer.",
            "startOffset": 20316,
            "title": "Discussion"
        },
        {
            "endOffset": 12409,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib28": {
                    "endOffset": 12407,
                    "startOffset": 12405
                }
            },
            "secId": "sec2.2",
            "sentence": "SPR was conducted using the Biacore S200 system (GE) with immobilisation of SubB2M performed as described previously [28].",
            "startOffset": 12287,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 16609,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "To verify that our method of detection using SubB2M was reliable, we also analysed the CA125-spiked serum samples with an anti-CA125 monoclonal antibody, clone X325.",
            "startOffset": 16444,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 21914,
            "parents": [],
            "secId": "sec4",
            "sentence": "For example, we noticed that the patient with the lowest Neu5Gc value recorded (specimen no. 08SH256) had elevated levels of CA19.9 (also known as sialyl Lewis A).",
            "startOffset": 21751,
            "title": "Discussion"
        },
        {
            "endOffset": 22821,
            "parents": [],
            "secId": "sec4",
            "sentence": "Our data showing uniformly elevated levels of Neu5Gc in the serum of ovarian cancer patients supports the latter hypothesis.",
            "startOffset": 22697,
            "title": "Discussion"
        },
        {
            "endOffset": 10764,
            "parents": [],
            "refoffsets": {
                "bib12": {
                    "endOffset": 10762,
                    "startOffset": 10760
                }
            },
            "secId": "sec1",
            "sentence": "Due to the limitations of CA125 as a biomarker, it is currently only approved by the FDA to be used to monitor the response to therapy and disease recurrence [12].",
            "startOffset": 10601,
            "title": "Introduction"
        },
        {
            "endOffset": 19772,
            "parents": [],
            "secId": "sec4",
            "sentence": "Using our engineered Neu5Gc specific lectin, SubB2M, we showed via SPR that Neu5Gc levels are significantly elevated in serum samples from ovarian cancer patients at stages I, II, IIIC and IV.",
            "startOffset": 19580,
            "title": "Discussion"
        },
        {
            "endOffset": 18534,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "Detailed information for each of the serum samples can be found in Supplementary Table 1.",
            "startOffset": 18445,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 10343,
            "parents": [],
            "refoffsets": {
                "bib4": {
                    "endOffset": 10341,
                    "startOffset": 10340
                }
            },
            "secId": "sec1",
            "sentence": "Serum CA125 levels are elevated in approximately 80% of ovarian cancer cases at the time of diagnosis [4].",
            "startOffset": 10237,
            "title": "Introduction"
        },
        {
            "endOffset": 13715,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib26": {
                    "endOffset": 13713,
                    "startOffset": 13711
                }
            },
            "secId": "sec2.2",
            "sentence": "SPR analysis was performed using multi-cycle analysis and double reference (values from flow cell 1 and 1% normal human serum only) subtraction using the Biacore S200 evaluation software, as previously described [26].",
            "startOffset": 13498,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 14931,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.3",
            "sentence": "Information regarding each of the serum samples used in this study is summarized in Supplementary Table 1.",
            "startOffset": 14825,
            "title": "Human serum samples"
        },
        {
            "endOffset": 23149,
            "parents": [],
            "secId": "sec4",
            "sentence": "SubB2M can detect Neu5Gc-glycans at early stages of ovarian cancer and detects uniformly high levels in late stage disease.",
            "startOffset": 23026,
            "title": "Discussion"
        },
        {
            "endOffset": 21528,
            "parents": [],
            "secId": "sec4",
            "sentence": "We noticed that with some of the serum samples, at concentrations above 1%, an over-saturation effect was occurring where the RUs would plateau then decrease.",
            "startOffset": 21370,
            "title": "Discussion"
        },
        {
            "endOffset": 19050,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.3",
            "sentence": "The CA125 levels in 14 of the ovarian cancer serum samples were provided by the Victorian Cancer Biobank and were determined within 7 days before or after collection of the serum sample used in our study.",
            "startOffset": 18846,
            "title": "Elevated Neu5Gc levels observed are not entirely due to elevated CA125 levels"
        },
        {
            "endOffset": 24475,
            "parents": [],
            "secId": "sec6",
            "sentence": "The following authors (JCP, AWP, CJD and MPJ) declare that they are named inventors on a patent on matter contained in this manuscript.",
            "startOffset": 24340,
            "title": "Disclosure"
        },
        {
            "endOffset": 13784,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "SPR analysis of human serum samples was performed as described above.",
            "startOffset": 13715,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 21017,
            "parents": [],
            "refoffsets": {
                "bib33": {
                    "endOffset": 21015,
                    "startOffset": 21013
                }
            },
            "secId": "sec4",
            "sentence": "However, the drawbacks of current commercial SPR sensors for clinical settings include their relatively large footprint and high cost [33].",
            "startOffset": 20878,
            "title": "Discussion"
        },
        {
            "endOffset": 23025,
            "parents": [],
            "secId": "sec4",
            "sentence": "Biomarkers that can monitor response to treatment and disease progression are also needed.",
            "startOffset": 22935,
            "title": "Discussion"
        },
        {
            "endOffset": 15658,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib3": {
                    "endOffset": 15650,
                    "startOffset": 15649
                },
                "bib30": {
                    "endOffset": 15653,
                    "startOffset": 15651
                },
                "bib32": {
                    "endOffset": 15656,
                    "startOffset": 15654
                }
            },
            "secId": "sec3.1",
            "sentence": "CA125 is heavily glycosylated, with 249 potential N-glycosylation and over 3700 potential O-glycosylation sites [3,30,32].",
            "startOffset": 15536,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 17830,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "We obtained a collection of ovarian cancer serum samples, along with normal female serum samples from a similar age range, from the Victorian Cancer Biobank.",
            "startOffset": 17673,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 16817,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "SubB2M showed concentration dependent recognition of CA125 (Fig. 1) and was able to detect down to 0.1465 CA125 units/ml in 1% serum.",
            "startOffset": 16684,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 12177,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.1",
            "sentence": "Briefly, SubB2M was expressed in E. coli BL21 (DE3) cells transformed with the SubB2M expression construct as a His6-tagged fusion protein, which was purified by Ni-NTA affinity chromatography.",
            "startOffset": 11984,
            "title": "Expression and purification of SubB2M"
        },
        {
            "endOffset": 11413,
            "parents": [],
            "refoffsets": {
                "bib22": {
                    "endOffset": 11199,
                    "startOffset": 11197
                },
                "bib23": {
                    "endOffset": 11202,
                    "startOffset": 11200
                },
                "bib24": {
                    "endOffset": 11249,
                    "startOffset": 11247
                }
            },
            "secId": "sec1",
            "sentence": "While there are analytical methods available [22,23] and a commercially available IgY antibody [24] for the detection of Neu5Gc, we improved upon this by developing a lectin with enhanced sensitivity and specificity for this glycan in complex biological samples.",
            "startOffset": 11151,
            "title": "Introduction"
        },
        {
            "endOffset": 18228,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "Fig. 2A shows the analysis of 12 stage I, 11 stage II, 10 stage IIIC and 14 stage IV ovarian cancer serum samples, as well as serum from 22 normal females via SPR.",
            "startOffset": 18065,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 24330,
            "parents": [],
            "secId": "sec5",
            "sentence": "This work was supported by National Health and Medical Research Council (NHMRC) Program Grant 1071659 (to JCP and MPJ), NHMRC Project Grant 1084050 (to AWP) and NHMRC Principal Research Fellowship 1138466 (to MPJ).",
            "startOffset": 24116,
            "title": "Funding"
        },
        {
            "endOffset": 11660,
            "parents": [],
            "refoffsets": {
                "bib25": {
                    "endOffset": 11655,
                    "startOffset": 11653
                },
                "bib26": {
                    "endOffset": 11658,
                    "startOffset": 11656
                }
            },
            "secId": "sec1",
            "sentence": "This improved Neu5Gc-specific lectin was termed SubB2M [25,26].",
            "startOffset": 11597,
            "title": "Introduction"
        },
        {
            "endOffset": 21750,
            "parents": [],
            "secId": "sec4",
            "sentence": "The molecular weight of the Neu5Gc-conjugates being detected by SubB2M via SPR may influence the RUs detected, with larger molecular structures potentially causing a greater refractive index shift resulting in higher RUs.",
            "startOffset": 21529,
            "title": "Discussion"
        },
        {
            "endOffset": 16892,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "This is equivalent to a sensitivity of 14.65 CA125 units/ml in 100% serum.",
            "startOffset": 16818,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 15985,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib30": {
                    "endOffset": 15809,
                    "startOffset": 15807
                }
            },
            "secId": "sec3.1",
            "sentence": "It has been shown that CA125 from the serum of patients with ovarian cancer has increased levels of sialylated glycans compared to normal controls [30], therefore we used CA125 in our SPR analysis as an example of the type of Neu5Gc-containing tumor antigens that would be expected to be overexpressed in human ovarian cancer.",
            "startOffset": 15659,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 11010,
            "parents": [],
            "refoffsets": {
                "bib13": {
                    "endOffset": 11005,
                    "startOffset": 11003
                },
                "bib14": {
                    "endOffset": 11008,
                    "startOffset": 11006
                }
            },
            "secId": "sec1",
            "sentence": "Glycans terminating with N-glycolylneuraminic acid (Neu5Gc) are not expressed at significant levels on healthy human tissues, as humans express an inactive cytidine monophosphate N-acetylneuraminic acid (Neu5Ac) hydroxylase (CMAH) enzyme [13,14].",
            "startOffset": 10764,
            "title": "Introduction"
        },
        {
            "endOffset": 17947,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "\u2018Normal\u2019 controls are defined as patients with an apparent non-malignancy diagnosis at the time the sample is taken.",
            "startOffset": 17831,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 10600,
            "parents": [],
            "refoffsets": {
                "bib10": {
                    "endOffset": 10542,
                    "startOffset": 10540
                },
                "bib11": {
                    "endOffset": 10598,
                    "startOffset": 10596
                },
                "bib5": {
                    "endOffset": 10444,
                    "startOffset": 10443
                },
                "bib6": {
                    "endOffset": 10459,
                    "startOffset": 10458
                },
                "bib7": {
                    "endOffset": 10478,
                    "startOffset": 10477
                },
                "bib8": {
                    "endOffset": 10511,
                    "startOffset": 10510
                },
                "bib9": {
                    "endOffset": 10526,
                    "startOffset": 10525
                }
            },
            "secId": "sec1",
            "sentence": "However, CA125 serum levels may also be elevated in nonmalignant conditions such as endometriosis [5], pregnancy [6], ovarian cysts [7], pelvic inflammatory disease [8], hepatitis [9], cirrhosis [10] and in the follicular phase of the menstrual cycle [11].",
            "startOffset": 10344,
            "title": "Introduction"
        },
        {
            "endOffset": 17068,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "These data confirm that SubB2M can detect Neu5Gc-containing human tumor antigens in the context of a complex sample, such as human serum, in a concentration-dependent fashion.",
            "startOffset": 16893,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 23426,
            "parents": [],
            "secId": "sec4",
            "sentence": "As a research reagent SubB2M has the potential to help identify novel Neu5Gc biomarkers for ovarian cancer.",
            "startOffset": 23319,
            "title": "Discussion"
        },
        {
            "endOffset": 14824,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.3",
            "sentence": "The Victorian Cancer Biobank, through the Cancer Council Victoria as Lead Agency, is supported by the Victorian Government through the Victorian Cancer Agency, a business unit of the Department of Health and Human Services.",
            "startOffset": 14601,
            "title": "Human serum samples"
        },
        {
            "endOffset": 19887,
            "parents": [],
            "secId": "sec4",
            "sentence": "The range of Neu5Gc levels obtained for the normal serum samples was from 26.32 to 73.48 SPR response units (RUs).",
            "startOffset": 19773,
            "title": "Discussion"
        },
        {
            "endOffset": 20877,
            "parents": [],
            "secId": "sec4",
            "sentence": "SPR is a highly sensitive, label-free, and rapid optical detection method and is increasingly being improved for clinical applications (see reference 33 for a recent review).",
            "startOffset": 20703,
            "title": "Discussion"
        },
        {
            "endOffset": 14045,
            "parents": [
                {
                    "id": "sec2",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec2.2",
            "sentence": "SPR analysis was performed using multi-cycle analysis and double reference (values from flow cell 1 and PBS buffer only) subtraction using the Biacore S200 evaluation software.",
            "startOffset": 13869,
            "title": "SPR analysis of CA125 spiked into normal human serum and detection of Neu5Gc glycans in human serum samples"
        },
        {
            "endOffset": 18444,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.2",
            "sentence": "We detected significantly elevated levels of Neu5Gc in serum samples from ovarian cancer patients in stage I, II, IIIC and IV compared to normal females, with consistently high levels observed in stages IIIC and IV.",
            "startOffset": 18229,
            "title": "SubB2M can detect elevated levels of Neu5Gc in serum samples in early and late stage ovarian cancer"
        },
        {
            "endOffset": 16684,
            "parents": [
                {
                    "id": "sec3",
                    "title": "Results"
                }
            ],
            "secId": "sec3.1",
            "sentence": "This mAb recognises epitope group B of CA125, similar to the M11 antibody.",
            "startOffset": 16610,
            "title": "SubB2M can detect CA125 spiked into normal human serum"
        },
        {
            "endOffset": 20703,
            "parents": [],
            "secId": "sec4",
            "sentence": "Moreover, Neu5Gc levels in all of the stage IIIC and IV samples exceeded the mean level plus 3 standard deviations for the age-matched normal sera, indicating high specificity and sensitivity.",
            "startOffset": 20511,
            "title": "Discussion"
        },
        {
            "endOffset": 21152,
            "parents": [],
            "secId": "sec4",
            "sentence": "Also, a range of dilutions of the serum samples had to be performed, with the data presented in this study obtained from 1% dilutions.",
            "startOffset": 21018,
            "title": "Discussion"
        }
    ],
    "docId": "S0006291X18323957",
    "metadata": {
        "asjc": [
            "1303",
            "1304",
            "1307",
            "1312"
        ],
        "authors": [
            {
                "email": null,
                "first": "L. K.",
                "initial": "L.K.",
                "last": "Shewell"
            },
            {
                "email": null,
                "first": "J. J.",
                "initial": "J.J.",
                "last": "Wang"
            },
            {
                "email": null,
                "first": "J. C.",
                "initial": "J.C.",
                "last": "Paton"
            },
            {
                "email": null,
                "first": "A. W.",
                "initial": "A.W.",
                "last": "Paton"
            },
            {
                "email": "c.day@griffith.edu.au",
                "first": "C. J.",
                "initial": "C.J.",
                "last": "Day"
            },
            {
                "email": "m.jennings@griffith.edu.au",
                "first": "M. P.",
                "initial": "M.P.",
                "last": "Jennings"
            }
        ],
        "doi": "10.1016/j.bbrc.2018.11.001",
        "firstpage": "173",
        "issn": "0006291X",
        "keywords": [
            "Biomarker",
            "Diagnostic",
            "Lectin",
            "N-glycolylneuraminic acid",
            "Neu5Gc",
            "Ovarian cancer"
        ],
        "lastpage": "177",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC"
        ],
        "title": "Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M"
    }
}